Neuralink
Pioneering brain-computer interfaces
Fremont, United States · Founded 2016 · $1.2B raised
- Headquarters
- Fremont, California
- Employees
- 201–500
- Founded
- 2016
- Business Model
- B2B
- Website
- neuralink.com
- Total Funding
- $1.2B
- Last Round
- $650.0M Series EJun 2025
- Rounds
- 5
About
Neuralink develops fully implantable, cosmetically invisible brain-computer interfaces designed to restore autonomy to people with unmet medical needs and unlock broader human potential. The company's N1 chip uses 1,024 electrodes on flexible threads to record and transmit neural signals wirelessly, enabling patients to control computers and mobile devices with thought.
Summary
Neuralink is a Biotech company based in Fremont, United States, founded in 2016. It has raised $1.2B in total across 5 rounds, most recently a $650.0M Series E round in Jun 2025. Investors include Founders Fund, Vy Capital and Elon Musk.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Founders Fund
3 rounds

Vy Capital
2 rounds
Elon Musk
2 rounds
ARK Invest
1 round

Sequoia Capital
1 round

Valor Equity Partners
2 rounds
DFJ
2 rounds

G42
1 round
Human Capital
1 round

Lightspeed VP
1 round
QIA
1 round
Thrive Capital
1 round
GV
1 round
Craft Ventures
1 round
Gigafund
1 round

Sam Altman
1 round
Fred Ehrsam
1 round
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company